Willingness of Older Adults From Culturally Diverse Populations to Participate in COVID-19 Related Treatment Trials and Associated Factors

Overview

Journal Gerontol Geriatr Med

Specialty Geriatrics

Date 2023 Jun 16

PMID 37324645

Authors

Ellen Leslie Brown

Amy Paul-Ward

Donna Felber Neff

Fern J Webb

Edgar Ramos Vieira

Trudy Gaillard

Affiliations

Soon will be listed here.

Abstract

This survey study aimed to assess the willingness of culturally diverse older adults to participate in COVID-19 research. The majority of the 276 participants were women (81%, = 223) and Black/African American (62%, = 172) or White Hispanic (20%, = 56). A key finding from the survey was less than 1 of 10 respondents would be likely to participate in COVID-19 related research if given the opportunity. There were no differences observed by gender, race or ethnicity. Implications of these findings are considered. These study findings indicate continued effort and better messaging strategies are required to increase awareness that COVID-19 related research needs to include culturally diverse older adults to ensure vaccines and treatments are efficacious in different populations.

References

Mackey K, Ayers C, Kondo K, Saha S, Advani S, Young S . Racial and Ethnic Disparities in COVID-19-Related Infections, Hospitalizations, and Deaths : A Systematic Review. Ann Intern Med. 2020; 174(3):362-373. PMC: 7772883. DOI: 10.7326/M20-6306. View

Xiao H, Vaidya R, Liu F, Chang X, Xia X, Unger J . Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials: A Systematic Review and Meta-analysis. JAMA Intern Med. 2022; 183(1):50-60. PMC: 9857303. DOI: 10.1001/jamainternmed.2022.5600. View

Cox C, Davis M, Grill J, Roberts J . US Adults' Likelihood to Participate in Dementia Prevention Drug Trials: Results from the National Poll on Healthy Aging. J Prev Alzheimers Dis. 2023; 10(1):34-40. PMC: 9579667. DOI: 10.14283/jpad.2022.86. View

Wong M, Brooks D, Ikejezie J, Gacic-Dobo M, Dumolard L, Nedelec Y . COVID-19 Mortality and Progress Toward Vaccinating Older Adults - World Health Organization, Worldwide, 2020-2022. MMWR Morb Mortal Wkly Rep. 2023; 72(5):113-118. PMC: 9927068. DOI: 10.15585/mmwr.mm7205a1. View

Lockett J, Sauma S, Radziszewska B, Bernard M . Adequacy of Inclusion of Older Adults in NIH-Funded Phase III Clinical Trials. J Am Geriatr Soc. 2019; 67(2):218-222. DOI: 10.1111/jgs.15786. View

Turner B, Steinberg J, Weeks B, Rodriguez F, Cullen M . Race/ethnicity reporting and representation in US clinical trials: a cohort study. Lancet Reg Health Am. 2022; 11. PMC: 9302767. DOI: 10.1016/j.lana.2022.100252. View

Milani S, Swain M, Otufowora A, Cottler L, Striley C . Willingness to Participate in Health Research Among Community-Dwelling Middle-Aged and Older Adults: Does Race/Ethnicity Matter?. J Racial Ethn Health Disparities. 2020; 8(3):773-782. PMC: 7431111. DOI: 10.1007/s40615-020-00839-y. View

Flores L, Muir R, Weeks I, Murray H, Silver J . Analysis of Age, Race, Ethnicity, and Sex of Participants in Clinical Trials Focused on Eating Disorders. JAMA Netw Open. 2022; 5(2):e220051. PMC: 8861843. DOI: 10.1001/jamanetworkopen.2022.0051. View

Warren R, Forrow L, Hodge Sr D, Truog R . Trustworthiness before Trust - Covid-19 Vaccine Trials and the Black Community. N Engl J Med. 2020; 383(22):e121. DOI: 10.1056/NEJMp2030033. View

10.

Frampton G, Shepherd J, Pickett K, Griffiths G, Wyatt J . Digital tools for the recruitment and retention of participants in randomised controlled trials: a systematic map. Trials. 2020; 21(1):478. PMC: 7273688. DOI: 10.1186/s13063-020-04358-3. View

11.

Lau S, Huang Y, Hsieh J, Wang S, Liu Q, Slattum P . Participation of Older Adults in Clinical Trials for New Drug Applications and Biologics License Applications From 2010 Through 2019. JAMA Netw Open. 2022; 5(10):e2236149. PMC: 9568796. DOI: 10.1001/jamanetworkopen.2022.36149. View